Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

ABVX vs FMS — Stock Comparison

Compare ABVX and FMS side-by-side on StoQuant: ABVX Q-Score 22 vs FMS 50; analyst signal 47 vs 50. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• ABVX — Abivax S.A. · Health Care · market cap $7.68B · Q-Score verdict Strong Sell (22.0, grade F) · analyst signal 47/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: competitive moat 91/100, ML forecast 44/100 · weakest signals: technicals 21/100, analyst consensus 8/100. Full ABVX research.
• FMS — Fresenius Medical Care AG & Co. KGaA · Health Care · market cap $12.39B · Q-Score verdict Unrated (50.0) · analyst signal 50/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: technicals 44/100, analyst consensus 15/100. Full FMS research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: ABVX research · FMS research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →